Author
Listed:
- Ming-Liang Lee
(Hokkaido University)
- Hirokazu Matsunaga
(Hokkaido University)
- Yuki Sugiura
(Keio University School of Medicine, Shinjuku-ku)
- Takahiro Hayasaka
(Hokkaido University)
- Izumi Yamamoto
(Hokkaido University)
- Taiga Ishimoto
(Hokkaido University)
- Daigo Imoto
(Hokkaido University)
- Makoto Suematsu
(Keio University School of Medicine, Shinjuku-ku)
- Norifumi Iijima
(National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki
Osaka University)
- Kazuhiro Kimura
(Hokkaido University)
- Sabrina Diano
(Columbia University Irving Medical Center
Yale University)
- Chitoku Toda
(Hokkaido University)
Abstract
The hypothalamus plays a central role in monitoring and regulating systemic glucose metabolism. The brain is enriched with phospholipids containing poly-unsaturated fatty acids, which are biologically active in physiological regulation. Here, we show that intraperitoneal glucose injection induces changes in hypothalamic distribution and amounts of phospholipids, especially arachidonic-acid-containing phospholipids, that are then metabolized to produce prostaglandins. Knockdown of cytosolic phospholipase A2 (cPLA2), a key enzyme for generating arachidonic acid from phospholipids, in the hypothalamic ventromedial nucleus (VMH), lowers insulin sensitivity in muscles during regular chow diet (RCD) feeding. Conversely, the down-regulation of glucose metabolism by high fat diet (HFD) feeding is improved by knockdown of cPLA2 in the VMH through changing hepatic insulin sensitivity and hypothalamic inflammation. Our data suggest that cPLA2-mediated hypothalamic phospholipid metabolism is critical for controlling systemic glucose metabolism during RCD, while continuous activation of the same pathway to produce prostaglandins during HFD deteriorates glucose metabolism.
Suggested Citation
Ming-Liang Lee & Hirokazu Matsunaga & Yuki Sugiura & Takahiro Hayasaka & Izumi Yamamoto & Taiga Ishimoto & Daigo Imoto & Makoto Suematsu & Norifumi Iijima & Kazuhiro Kimura & Sabrina Diano & Chitoku T, 2021.
"Prostaglandin in the ventromedial hypothalamus regulates peripheral glucose metabolism,"
Nature Communications, Nature, vol. 12(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22431-6
DOI: 10.1038/s41467-021-22431-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22431-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.